FDA Approves Diaphragm-Pacing Device
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




FDA Approves Diaphragm-Pacing Device

NEW YORK -- June 18, 2008 -- The US Food and Drug Administration (FDA) announced today that it approved the NeuRx RA/4 Diaphragm Pacing System (DPS), an implantable electronic device that stimulates the diaphragm and allows certain patients with spinal cord injury to breathe for at least 4 hours a day without a mechanical ventilator.

"While the NeuRx RA/4 does not cure paralysis of the diaphragm, allowing patients to be free from a mechanical ventilator for at least 4 hours a day may enhance their quality of life," said Daniel G. Schultz, MD, Center for Devices and Radiological Health, FDA, Rockville, Maryland.

The NeuRx DPS RA/4 uses 4 electrodes implanted in the muscle of the diaphragm to electronically stimulate contraction, thus allowing the patient to inhale.

The FDA approved the distribution of this device under a Humanitarian Device Exemption, an approval process for devices intended to treat or diagnose conditions that affect fewer than 4,000 people per year.

In a multicentre trial, the device has been demonstrated to be safe and to have probable benefit to the patient by allowing at least 4 hours per day of freedom from a mechanical ventilator.

SOURCE: US Food and Drug Administration

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities